MicroRNA-34a negatively regulates anesthesia-induced hippocampal apoptosis and memory impairment through FGFR1

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 10, 2014, Pages 6760-6767

  Jiang, Xiu Li ^a   Du, Bo Xiang ^a   Chen, Jie ^a   Liu, Lin ^a   Shao, Wei Bin ^a   Song, Jie ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Anesthesia; FGFR1; Hippocampus; MiR 34a; Neurotoxicity

Indexed keywords

ANESTHETIC AGENT; FGFR1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; KETAMINE; MICRORNA; MIRN34 MICRORNA, MOUSE;

ANIMAL; ANIMAL BEHAVIOR; APOPTOSIS; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; HIPPOCAMPAL CA1 REGION; MAZE TEST; MEMORY; MEMORY DISORDER; METABOLISM; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANESTHETICS, DISSOCIATIVE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BEHAVIOR, ANIMAL; CA1 REGION, HIPPOCAMPAL; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; KETAMINE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE, INBRED C57BL; MICRORNAS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84912124548     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Flick RP, Nemergut ME, Christensen K and Hansen TG. Anesthetic-related neurotoxicity in the young and outcome measures: the devil is in the details. Anesthesiology 2014; 120: 1303-1305.
2. Olsen EA and Brambrink AM. Anesthetic neurotoxicity in the newborn and infant. Curr Opin Anaesthesiol 2013; [Epub ahead of print].
3. Loepke AW and Soriano SG. An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function. Anesth Analg 2008; 106: 1681-1707.
4. Kohrs R and Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg 1998; 87: 1186-1193.
5. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT and Sesma MA. NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991; 254: 1515-1518.
6. Huang L, Liu Y, Jin W, Ji X and Dong Z. Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCgamma-ERK signaling pathway in the developing brain. Brain Res 2012; 1476: 164-171.
7. Huang L, Liu Y, Zhang P, Kang R, Li X, Bo L and Dong Z. In vitro dose-dependent inhibition of the intracellular spontaneous calcium oscillations in developing hippocampal neurons by ketamine. PLoS One 2013; 8: e59804.
8. Peng S, Zhang Y, Zhang J, Wang H and Ren B. Effect of ketamine on ERK expression in hippocampal neural cell and the ability of learning behavior in minor rats. Mol Biol Rep 2010; 37: 3137-3142.
9. Wang C, Liu F, Patterson TA, Paule MG and Slikker W Jr. Preclinical assessment of ketamine. CNS Neurosci Ther 2013; 19: 448-453.
10. Zou X, Patterson TA, Divine RL, Sadovova N, Zhang X, Hanig JP, Paule MG, Slikker W, Jr. and Wang C. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci 2009; 27: 727-731.
11. Volvert ML, Rogister F, Moonen G, Malgrange B and Nguyen L. MicroRNAs tune cerebral cortical neurogenesis. Cell Death Differ 2012; 19: 1573-1581.
12. Miranda RC. MicroRNAs and Fetal Brain Development: Implications for Ethanol Teratology during the Second Trimester Period of Neurogenesis. Front Genet 2012; 3: 77.
13. Wu D and Murashov AK. MicroRNA-431 regulates axon regeneration in mature sensory neurons by targeting the Wnt antagonist Kremen1. Front Mol Neurosci 2013; 6: 35.
14. Singh P, Soon PS, Feige JJ, Chabre O, Zhao JT, Cherradi N, Lalli E and Sidhu SB. Dysregulation of microRNAs in adrenocortical tumors. Mol Cell Endocrinol 2012; 351: 118-128.
15. Bithell A, Johnson R and Buckley NJ. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease. Biochem Soc Trans 2009; 37: 1270-1275.
16. Goedeke L and Fernandez-Hernando C. microRNAs: A connection between cholesterol metabolism and neurodegeneration. Neurobiol Dis 2014; [Epub ahead of print].
17. Rathod SS, Rani SB, Khan M, Muzumdar D and Shiras A. Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways. FEBS Open Bio 2014; 4: 485-495.
18. Silber J, Jacobsen A, Ozawa T, Harinath G, Pedraza A, Sander C, Holland EC and Huse JT. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS One 2012; 7: e33844.
19. Rokavec M, Li H, Jiang L and Hermeking H. The p53/miR-34 axis in development and disease. J Mol Cell Biol 2014; 6: 214-230.
20. Patil SS, Sunyer B, Hoger H and Lubec G. Evaluation of spatial memory of C57BL/6J and CD1 mice in the Barnes maze, the Multiple T-maze and in the Morris water maze. Behav Brain Res 2009; 198: 58-68.
21. Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D, Forsythe ID, Young KW, Ventura A, Concepcion CP, Han YC, Candi E, Knight RA, Mak TW and Melino G. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci U S A 2011; 108: 21099-21104.
22. Hu K, Xie YY, Zhang C, Ouyang DS, Long HY, Sun DN, Long LL, Feng L, Li Y and Xiao B. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci 2012; 13: 115.
23. Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L and Qin C. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 2009; 80: 268-273.
24. Turner CA, Calvo N, Frost DO, Akil H and Watson SJ. The fibroblast growth factor system is downregulated following social defeat. Neurosci Lett 2008; 430: 147-150.
25. Bryckaert M, Guillonneau X, Hecquet C, Courtois Y and Mascarelli F. Both FGF1 and bcl-x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal-regulated kinase 2. Oncogene 1999; 18: 7584-7593.